Cantor Fitzgerald initiated coverage citing a durable business model, and Morgan Stanley provided analyst commentary on Samsara.
2 reports, 1 independent
Updated Sep 22
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald initiated coverage citing a durable business model, and Morgan Stanley provided analyst commentary on Samsara.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
Samsara
IT company
-
Morgan Stanley
U.S. investment bank
Related events
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.
- Cantor Fitzgerald restated an overweight rating for Anteris Technologies Global Corp. on October 8, 2026.
- Cantor Fitzgerald maintained a Buy rating on Meta.
- Briefing.com reported a rating change issued by Cantor Fitzgerald.
- Multiple financial firms, including Cantor Fitzgerald and William Blair, issued rating updates and price targets for various stocks on August 10, 2026.